Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia.
Kellen B GilDiana AbbottMaria L AmayaMarc SchwartzJonathan A GutmanAndrew KentGrace BosmaDaniel A PollyeaChristine M McMahonPublished in: Leukemia & lymphoma (2024)